Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The EURODIAB IDDM Complications Study involved the examination of 3250 randomly selected insulin-dependent diabetic patients, from 31 centres in 16 European countries. Part of the examination included an assessment of neurological function including neuropathic symptoms and physical signs, vibration perception threshold, tests of autonomic function and the prevalence of impotence. The prevalence of diabetic neuropathy across Europe was 28% with no significant geographical differences. Significant correlations were observed between the presence of diabetic peripheral neuropathy with age (p < 0.05), duration of diabetes (p < 0.001), quality of metabolic control (p < 0.001), height (p < 0.01), the presence of background or proliferative diabetic retinopathy (p < 0.01), cigarette smoking (p < 0.001), high-density lipoprotein cholesterol (p < 0.001) and the presence of cardiovascular disease (p < 0.05), thus confirming previous associations. New associations have been identified from this study - namely with elevated diastolic blood pressure (p < 0.05), the presence of severe ketoacidosis (p < 0.001), an increase in the levels of fasting triglyceride (p < 0.001), and the presence of microalbuminuria (p < 0.01). All the data were adjusted for age, duration of diabetes and HbA1c. Although alcohol intake correlated with absence of leg reflexes and autonomic dysfunction, there was no overall association of alcohol consumption and neuropathy. The reported problems of impotence were extremely variable between centres, suggesting many cultural and attitudinal differences in the collection of such information in different European countries. In conclusion, this study has identified previously known and new potential risk factors for the development of diabetic peripheral neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, even in more contemporary cohorts with recent-onset T2D prevalence rates of up to 25% have been observed,545,546 including in youth417,612–615 or at different degrees of glucose intolerance.616”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [545]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Young, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Dyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482
The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes
Ewing, D. J., Martyn, C. N., Young, R. J., & Clarke, B. F. (1985) · Diabetes Care · doi:10.2337/diacare.8.5.491 · Cited by 1,434 · cited 1×
“1) the presence of one or more symptoms; 2) absence of two or more ankle or knee reflexes; 3) vibration perception threshold which was abnormal relating to age-related measures [12] and 4) abnormal autonomic function assessed using Ewing’s definitons [13] of postural hypotension with a fall in systolic blood pressure…”
MethodPirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.3.168 · Cited by 1,290
Maser, R. E., Steenkiste, A. R., Dorman, J. S., Nielsen, V. K., Bass, E. B., Manjoo, Q., Drash, A. L., Becker, D. J., Kuller, L. H., Greene, D. A., et al. (1989) · Diabetes · doi:10.2337/diab.38.11.1456 · Cited by 408
Pirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.4.252 · Cited by 358
Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study
Stephenson, J., Fuller, J. H., & EUROBIAB IDDM Complications Study Group (1994) · Diabetologia · doi:10.1007/bf00398055 · Cited by 345
Self-citationReport and Recommendations of the San Antonio Conference on Diabetic Neuropathy
(1988) · Diabetes · doi:10.2337/diab.37.7.1000 · Cited by 308
Malik, R. A., Newrick, P. G., Sharma, A. K., Jennings, A., Ah-See, A. K., Mayhew, T. M., Jakubowski, J., Boulton, A. J. M., & Ward, J. D. (1989) · Diabetologia · doi:10.1007/bf00505180 · Cited by 294
Self-citationSENSORY NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES MELLITUS
FRANKLIN, G. M., KAHN, L. B., BAXTER, J., MARSHALL, J. A., & HAMMAN, R. F. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115547 · Cited by 281
Cited by
Items 501–600 of 693
Marcovecchio, M. L., & Dunger, D. B. (2012) · Diabetes Management · doi:10.2217/dmt.12.67 · Cited by 4
Jin, H. Y., Piao, M. H., Park, J. H., Baek, H. S., Lee, S., Kim, W. B., Park, S. K., Kim, C. H., Koh, G. Y., & Park, T. S. (2008) · Current Therapeutic Research · doi:10.1016/j.curtheres.2008.08.002 · Cited by 3
Erden, Y., Korğalı, E., Dündar, G., Ayan, S., Gökçe, G., Yıldırım, Ş., & Gültekin, E. Y. (2014) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2014.1.33 · Cited by 3
PAINFUL PERIPHERAL NEUROPATHY: DIAGNOSIS AND ASSESSMENT
Freeman, R. L. (2009) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000348852.20265.fe · Cited by 3
Boulton, A. J. M., & Malik, R. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00053-8 · Cited by 3
Protection from neuropathy in extreme duration type 1 diabetes
Azmi, S., Ferdousi, M., Kalteniece, A., Petropoulos, I. N., Ponirakis, G., Alam, U., Asghar, O., Marshall, A. G., Sankar, A., Boulton, A. J. M., et al. (2020) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12423 · Cited by 3
“The EURODIAB study has previously shown that the duration of diabetes, cigarette smoking, BMI, blood pressure and triglycerides were associated with the development of neuropathy in a cohort of people with T1DM.(28) A higher HDL-C has been associated with protection from the development of retinopathy and nephropathy,…”
BackgroundMain metabolic and toxic polyneuropathies in clinical practice
Пизова, Н. В. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-19-134-146 · Cited by 3
Diabetic Autonomic and Peripheral Neuropathy
Donaghue, K. C., Al-Jasser, A., & Maguire, A. (2005) · KARGER eBooks · doi:10.1159/000085802 · Cited by 3
Sankari, H., Vishnu, R., Bazroy, J., & Singh, Z. (2015) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20150791 · Cited by 3
SEXUAL FUNCTION IN MEN WITH DIABETES TYPE 2:
Romeo, J. H., Seftel, A. D., Madhun, Z. T., & &NA;, D. C. A. (2000) · The Journal of Urology · doi:10.1097/00005392-200003000-00020 · Cited by 3
Methods of Assessing the Quality of Diabetes Care
Fuller, J. (1998) · Hormone Research in Paediatrics · doi:10.1159/000053107 · Cited by 3
Self-citationThe Pathogenesis of Foot Problems
Shaw, J. E., & Boulton, A. J. M. (1998) · Humana Press eBooks · doi:10.1007/978-1-4612-1816-6_18 · Cited by 3
Anastasiou, G., Παπάνας, Ν., Barkas, F., Tentolouris, N., Liamis, G., Michalis, L. K., Bechlioulis, A., Kalaitzidis, R., & Liberopoulos, E. N. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113140 · Cited by 2
Smartphone-based App to Assess Diabetic Peripheral Neuropathy
Adenekan, R. A. G., Adenekan, A. E., Leung, K. K., Muppidi, S., Sakamuri, S., Tan, M. J., Tsai, S. A., Osikomaiya, M., Okamura, A. M., Nunez, C. M., et al. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261426385 · Cited by 2
Peripheral Neuropathy and Associated Factors in Diabetics at the CNHU-HKM of Cotonou in 2021
Hodé, A. K., Dedjan, H., & Sondjo, F. M. (2023) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2023.131002 · Cited by 2
Diabetic Peripheral Neuropathy
Nardin, R. A., & Freeman, R. L. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_19 · Cited by 4
Investigation of the Risk Factors of Diabetic Neuropathy in terms of Pain, Sleep and Quality of Life
Ekici, G., Celenay, S. T., & Büyükturan, Ö. (2017) · Türk fizyoterapi ve rehabilitasyon dergisi · doi:10.21653/tfrd.330523 · Cited by 2
Precision Medicine for Diabetic Neuropathy
Davalos, L., Stino, A. M., Selvarajah, D., Sakowski, S. A., Tesfaye, S. H., & Feldman, E. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_8 · Cited by 2
Self-citationWang, L., Guan, B., Li, G., Feng, L., Hui, S., & Xu, J. (2022) · Medicine · doi:10.1097/md.0000000000031467 · Cited by 3
“[10] Diabetes duration,[11,12] age,[11–14] HbA1c,[15,16] smoking,[17] body mass index, and fasting plasma glucose[18,19] are all risk factors for DPN.”
Clinical Diagnosis of Diabetic Peripheral Neuropathy
Perkins, B. A., & Bril, V. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_5 · Cited by 3
(GSEDNu), G. D. N. D. L. S. E. D. D. (2005) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(05)71047-0 · Cited by 2
Frequency of Distal Sensory Polyneuropathy among Diabetics in Parakou in 2012
Thierry, A., Kouna‐Ndouongo, P., Justine, S. B., Imorou, A., & Houinato, D. S. (2015) · Neuroscience & Medicine · doi:10.4236/nm.2015.63016 · Cited by 2
Frystyk, J., Skjærbæk, C., Vestbo, E., Fisker, S., & Ørskov, H. (1999) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(199909/10)15:5<314::aid-dmrr56>3.0.co;2-e · Cited by 304
Tratamiento de las complicaciones neuropáticas de la diabetes mellitus
Pérez‐Ferre, N., & Pascual, A. L. C. (2008) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(08)76270-3 · Cited by 4
Pradat, P., & Mallet, J. J. (2003) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2003.10648037 · Cited by 2
Pandya, N., Desai, K. S., Goswami, T. M., Patel, V., Mevada, A. K., & Suthar, M. (2013) · International Journal of Biomedical and Advance Research · doi:10.7439/ijbar.v4i3.323 · Cited by 2
Neurologic diseases, epidemiology, and public health
Kukull, W. A., & Bowen, J. (2009) · Oxford University Press eBooks · doi:10.1093/med/9780199218707.003.0067 · Cited by 2
Diyabetik Polinöropati için Risk Faktörleri
Kaplan, Y., Kurt, S. G., Ünaldı, H. K., & Erkorkmaz, Ü. (2014) · Nöro Psikiyatri Arşivi · doi:10.4274/npa.y6303 · Cited by 2
Glycaemic indices and haemoglobin A1c as predictors for non-healing ulcers
Moore, K. J., Dunn, E. C., Marcus, E. N., & Koru‐Sengul, T. (2018) · Journal of Wound Care · doi:10.12968/jowc.2018.27.sup4.s6 · Cited by 5
Role of Growth Factors in the Treatment of Diabetic Foot Ulceration
Singh, D., & Siddique, H. R. (2020) · Springer eBooks · doi:10.1007/978-981-15-7639-3_15 · Cited by 2
Tesfaye, S. H. (1998) · Humana Press eBooks · doi:10.1007/978-1-4612-1816-6_9 · Cited by 2
Self-citationNeuropatia diabetica in Italia
Spallone, V. (2012) · Cineca Institutional Research Information System (Tor Vergata University) · Cited by 2
Effects of Pancreas Transplantation on Secondary Complications of Diabetes
Fioretto, P., Mauer, M. S., Walsh, A. W., Elliott, M. D., Chen, M., Kaufman, D. B., Navarro, X., Kennedy, W. R., Gaber, A. O., Cashion, A. K., et al. (2004) · Springer eBooks · doi:10.1007/978-1-4757-4371-5_16 · Cited by 2
Neurophysiological evaluation in newly diagnosed Diabetes Mellitus type 1
Matanović, D., Popović, S., Parapid, B. J., Petronić, I., & Nikolić, D. (2013) · Open Medicine · doi:10.2478/s11536-013-0181-6 · Cited by 2
Epidemiology of Acute Complications in Youth: Diabetic Ketoacidosis and Hypoglycemia
Rewers, A. (2008) · CRC Press eBooks · doi:10.3109/9781420047981-17 · Cited by 4
Adam, K. M., Tajelsir, S., & Aowad, D. A. (2016) · OALib · doi:10.4236/oalib.1102634 · Cited by 2
Prise en charge de la polyneuropathie diabétique douloureuse
Hartemann, A., Attal, N., Bouhassira, D., Dumont, I., Gin, H., Jeanne, S., Saïd, G., & Richard, J.-L. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70227-9 · Cited by 2
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neuman, S. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-1 · Cited by 2
Cabré, J. J., Mur, T., Costa, B., Barrio, F., López-Moya, C., Sagarra-Alamo, R., García-Barco, M., Vizcaíno, J., Bonaventura, I., Ortiz, N., et al. (2018) · Medicine · doi:10.1097/md.0000000000010750 · Cited by 2
Diagnosis and Management of Diabetic Autonomic Neuropathy
Kim, C. H. (2018) · Journal of Korean Diabetes · doi:10.4093/jkd.2018.19.3.160 · Cited by 2
Clinical manifestations of nervous system impairments in diabetes mellitus
Пизова, Н. В. (2018) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2018-9-104-111 · Cited by 2
Duan, Y., Liu, A., Hongxia, S., Lv, J.-H., Gong, X., & Wang, L. (2020) · Medicine · doi:10.1097/md.0000000000020366 · Cited by 2
Nanotechnology and Diabetic Foot Ulcer: Future Prospects
Ansari, M. A., Ali, K., Farooqui, Z., Al-Dossary, H. A., Zubair, M., & Musarrat, J. (2020) · Springer eBooks · doi:10.1007/978-981-15-7639-3_20 · Cited by 3
Nalluri, L., Mannam, M., Vemireddy, N., Akula, N., Pothuraju, M., Pinnika, D., Sudagani, J., Pingili, R. B., & Kilaru, N. B. (2019) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2019.91210 · Cited by 2
“The prevalence of DPN varies largely across regions from 5% to 60% (Davies et al., 2006; Tesfaye and Selvarajah, 2012; Tesfaye et al., 1996; Young et al., 1993).”
BackgroundEficacia de la gabapentina y de la amitriptilina en el dolor neuropático del diabético
Vidal, M. A., Martinez-Fernandez, E., Morera, L. M. T., & de Castro, J. M. V. (2004) · Dialnet (Universidad de la Rioja) · Cited by 2
Sima, A. A. F., Zhang, W., & Kamiya, H. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-311-0_8 · Cited by 2
Evidence-based pharmacological management of chronic neuropathic pain
Ansari, Z. (2013) · International Journal of Basic & Clinical Pharmacology · doi:10.5455/2319-2003.ijbcp20130601 · Cited by 1
Patil, Y., Singaravelan, R. M., & Borkar, T. P. (2021) · Indian Journal of Public Health Research & Development · doi:10.37506/ijphrd.v12i4.16577 · Cited by 1
Majumdar, M., Banerjee, M., Sengupta, J., Deb, S., Jana, C. K., & Roy, B. K. (2023) · International Journal of Advanced Research · doi:10.21474/ijar01/17167 · Cited by 1
Durgavathi, C., Deepa, K., Daniel, S. J., & Sampath, V. (2024) · IP Indian Journal of Clinical and Experimental Dermatology · doi:10.18231/j.ijced.2024.009 · Cited by 1
Šiaulienė, L., Sereikė, I., Lazutka, J. R., Semigrejevienė, J., & Visockienė, Ž. (2025) · Diabetology · doi:10.3390/diabetology6080074 · Cited by 1
Sztanek, F., Pető, A., Tóth, L. I., Lőrincz, H., Molnár, Á., Lukács, M., Menyhárt, A., Kempler, P., Paragh, G., Harangi, M., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14165780 · Cited by 1
“The global prevalence of neuropathy among people with diabetes is estimated to range from 20% to 50% [2,3].”
Baszyńska–Wilk, M., Nowacka-Gotowiec, M., & Moszczyńska, E. (2025) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2025.2025-3-29 · Cited by 1
“According to EURODIAB the risk factors for DPN in youth with T1D are increased diastolic blood pressure (9).”
InfluentialMigdalis, I. N., Tentolouris, N., Didangelos, T., Παπάνας, Ν., Bristianou, M., Mavrogiannaki, A. N., & Study, O. B. O. T. P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196723 · Cited by 4
Integrating gut microbiota into multidisciplinary perspectives on diabetic neuropathy
Horiachok, M., Potapova, K., Ivanykovych, T., Yerokhovych, V., Ilkiv, Y., & Sokolova, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1710868 · Cited by 1
Lee, C., Han, K., Yoo, J., Park, K., & Oh, S. Y. (2025) · Eye · doi:10.1038/s41433-025-04011-w · Cited by 1
Eilers, M., Fellmann, M., l'Allemand, D., Wurster, J., Meier, S., Lütschg, J., Gruener, M., West, E., Muhitira, U., Oberhauser, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-32309-y · Cited by 1
Mechanisms and Clinical Application Progress of Exercise in the Treatment of Neuropathic Pain
Li, X., & JinZhu, B. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01678-x · Cited by 1
“Diabetic peripheral neuropathy (DPN) is among the most common chronic complications of diabetes, with a prevalence ranging from 6 to 51% (Abbott et al. 2011 ; Hicks and Selvin 2019; Tesfaye et al. 1996; Gregg et al. 2007).”
Cheng, K. H., Kubi, J. A., Brah, A. S., Asante, M. Y., Zhu, Y., & Yeung, K. (2026) · Regenerative medicine and dentistry. · doi:10.53941/rmd.2026.100002 · Cited by 1
“The EURODIAB IDDM Complications Study, including 3,250 patients in 16 European countries, reported a prevalence of DPN in type 1 diabetes of 28% with no significant geographic differences [8].”
Bombaci, B., Bassi, M., Castorani, V., Candia, F. D., Ferrari, M., Martino, M., Zagaroli, L., Marigliano, M., Bonfanti, R., Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology, et al. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02646-z · Cited by 1
Differential diagnosis of polyneuropathies in diabetes mellitus
Khramilin, V. N. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-256-265 · Cited by 1
Hajaš, G. (2018) · Neurologie pro praxi · doi:10.36290/neu.2018.003 · Cited by 1
“Zistila 28 % prevalenciu klinickej neuropatie, bez preukázania signifikantných geografických rozdielov (Tesfaye et al., 1996).”
BackgroundInfluentialDevelopment of risk prediction scores for diabetic peripheral neuropathy patients
Laxmi, M. S., & Orsu, P. (2023) · Journal of Neurosciences in Rural Practice · doi:10.25259/jnrp_151_2023 · Cited by 1
“…earlier research that uncontrolled hyperglycemia increases the risk of DPN in T2DM, and that glycemic control can slow the progression of DPN. [13] Our study confirmed previous findings [14,15] that DPN is more prevalent among individuals with dyslipidemia, and that elevated triglyceride…”
Wickramasinghe, T. P., Subasinghe, S., Withana, A. K. G., & Wellala, D. A. H. (2016) · Journal of the Ceylon College of Physicians · doi:10.4038/jccp.v47i1.7765 · Cited by 1
Lozeron, P. (2017) · EMC - Neurologia · doi:10.1016/s1634-7072(16)81776-6 · Cited by 1
Perspectives on the Vascular Pathogenesis of Diabetic Neuropathy
Mahadevan, A., & Krishna, S. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_10 · Cited by 1
Sami, W., Ansari, T., Butt, N. S., & Hamid, M. R. A. (2018) · Pakistan Journal of Statistics and Operation Research · doi:10.18187/pjsor.v14i2.2249 · Cited by 4
“It has been stated in another study that dietary pattern and food selection is influenced by patient’s knowledge related to recommended diet (Tesfaye et al., 1996).”
BackgroundResultCao, B., Yao, Y., Xu, Y., Fang, J., Song, W., Hu, B., Guo, Q., Lü, B., Li, J., Gu, P., et al. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0950-9828 · Cited by 1
Screening For Peripheral Sensory Neuropathy In a Tunisian Population of Patients With Diabetes
Jemai, C., Frigui, S., & Mami, F. B. (2020) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2020.2.4.382 · Cited by 1
“[15] Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al.”
BackgroundRisk factors associated with peripheral neuropathy among diabetic individuals: a case control study
Kingston, C., Aravindan, J., & Walsalam, S. (2021) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20210236 · Cited by 1
“51).(22-24) The variations in association of diabetic peripheral neuropathy with body mass index may be due to the difference between developed and developing countries.”
BackgroundAutonomic Diabetic Polyneuropathy Variants: Possible Correction
Zilov, A. V., & Moscow, R. F. (2021) · Doctor Ru · doi:10.31550/1727-2378-2021-20-2-60-66 · Cited by 1
Tesfaye, S. H., & Wu, J. (2018) · Contemporary diabetes · doi:10.1007/978-3-319-89869-8_3 · Cited by 1
Self-citationVas, P. R. J., & Mahdi‐Rogers, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-17918-6_3 · Cited by 1
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_10 · Cited by 1
Oleiwi, S. R. (2020) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v14i1.217 · Cited by 1
(2021) · Ultrasound & Functional Diagnostics · doi:10.24835/1607-0771-2020-4-78-97 · Cited by 1
Neuropathy in Type 1 and Type 2 Diabetes
Akıncı, G., Nowacek, D. G., & Callaghan, B. C. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_4 · Cited by 1
The Role of Lipids and Lipoproteins in Peripheral Neuropathy
Collazos-Alemán, J. D., Salazar-Ocampo, M. P., & Mendivil, C. O. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_18 · Cited by 1
Factors associated with developing symptomatic HIV-associated sensory neuropathy
Wadley, A. L. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 1
Disturbances of Pain Perception in Disorders of the Peripheral Nervous System
Schepelmann, K. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9068-6_10 · Cited by 1
Outcome of Ischaemic Foot Ulcers in Patients with Diabetes, with or without Revascularization
Elgzyri, T. (2014) · Lund University Publications (Lund University) · Cited by 1
Abdelhafiz, A. H., & Sinclair, A. J. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch55
Management of neuropathic pain
Boulton, A. J. M., & Vileikytė, L. (2011) · doi:10.1007/978-1-908517-16-6_4 · Cited by 1
Chinese herbal medicine for diabetic peripheral neuropathy
Chen, W., Li, Z., & Liu, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007796 · Cited by 2
Chronic Complications of Childhood Diabetes
Donaghue, K. C., Mohsin, F., & Stone, M. (2008) · CRC Press eBooks · doi:10.3109/9781420047981-15 · Cited by 1
Duim-Beytell, M. C. (2007) · UpSpace Institutional Repository (University of Pretoria)
Londero, G. F. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Peripheral nerve function : metabolic features, clinical assessment, and heat shock protein 27
Pourhamidi, K. (2013) · DiVA at Umeå University (Umeå University)
Microvascular and Macrovascular Complications in Children and Adolescents with Type 1 Diabetes
Chiarelli, F., & Marcovecchio, M. L. (2011) · InTech eBooks · doi:10.5772/22029 · Cited by 1
“2 Blood pressure and plasma lipids Elevated blood pressure and alterations in its circadian rhythm are common findings in people with type 1 diabetes and have been associated with the risk of developing vascular complications (Gallego et al., 2008; Marcovecchio et al., 2009b; Tesfaye et al., 1996).”
BackgroundManagement of Neuropathic Pain
Boulton, A. J. M., & Vileikytė, L. (2011) · Springer eBooks · doi:10.1007/978-0-85729-488-3_4
Lithovius, R. (2015) · Helda - University of Helsinki Institutional Repository
Epidemiology and Natural History of DPN
Malik, R. A. (2005) · Wiley eBooks · doi:10.1002/9780470751503.ch10
A comparison of the anatomical and biomechanical parameters of the foot in Maori and non-Maori
Ihaka, B. (2014) · Tuwhera (Auckland University of Technology)
Introduction to Diabetic Neuropathies
Boulton, A. J. M., & Vileikytė, L. (2011) · Springer eBooks · doi:10.1007/978-0-85729-488-3_1
The role of the sympathetic nervous system in the pathomechanism and the therapy of hypertension
Légrády, P. (2014) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.2145 · Cited by 1
Psychosocial factors and type 1 diabetes
Fickley, C. E. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
DIABETIC PERIPHERAL NEUROPATHY AND RETINAL TISSUE THICKNESS
Srinivasan, S. (2014)
Proliferative Diabetic Retinopathy: Current Treatment Strategies for Progression
Scheindlin, J. A. (2002) · Springer eBooks · doi:10.1007/978-94-010-0614-9_9
4th Biennial Scottish Conference on the diabetic foot
Reeves, K. (2003) · Practical Diabetes · doi:10.1002/pdi.561
Chronic diabetic complications in clinically, immunologically and genetically defined subgroups
Isomaa, B. (2001) · Helda - University of Helsinki Institutional Repository · Cited by 1
Metadata
- Authors
- Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D.
- Affiliations
- Royal Liverpool University Hospital (GB)
- University College London (GB)
- Royal Hallamshire Hospital (GB)
- München Klinik Schwabing (DE)
- IRCCS Ospedale San Raffaele (IT)
- Venue
- Diabetologia
- Published
- 1996-10-23
- Volume
- 39
- Issue
- 11
- Pages
- 1377-1384
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2049568996
- Cited by
- 695
- References
- 30
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 17 · 2023: 30 · 2022: 27 · 2021: 34 · 2020: 32 · 2019: 30 · 2018: 35 · 2017: 23 · 2016: 27 · 2015: 36 · 2014: 41 · 2013: 36 · 2012: 27
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Pfizer
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, prevalence, type 1 diabetes, glycemic control, risk factors, diabetes duration, diabetic retinopathy, smoking, HDL cholesterol, cardiovascular disease, diastolic blood pressure, ketoacidosis, fasting triglycerides, microalbuminuria, autonomic dysfunction, erectile dysfunction, alcohol consumption
- MeSH terms
- Adolescent, Adult, Blood Pressure, Body Constitution, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Diabetic Retinopathy, Europe, Female, Humans, Hypoglycemia, Lipids, Male, Middle Aged, Peripheral Nervous System Diseases, Regression Analysis, Risk Factors, Smoking, Body Mass Index, Prevalence, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.